Michael J. Blankenship, Office Managing Partner and Co-Chair of the Capital Markets Group at Winston & Strawn LLP, discusses essential regulatory considerations and strategies for navigating international IPOs and M&A transactions. With extensive experience across the energy, healthcare and technology sectors, Michael covers the intricacies of regulatory environments in different countries, the impact of fluctuations in the tech sector and how the US elections may shape the IPO landscape.
Key Takeaways:
(04:59) Helping emerging companies reduce IPO regulatory burdens.
(06:24) Differences in regulatory standards between the US and Europe.
(08:10) Anticipated post-election increase in US transactions.
(09:51) Inverse relationship between technology and energy sectors.
(12:13) Capital-intensive needs in the healthcare sector.
(15:24) Overlooked regulatory consent pitfalls in healthcare.
(20:37) The importance of tailored diligence lists and data rooms.
(23:21) Compliance differences in IPOs versus M&A processes.
(28:46) Employee classification diligence in global transactions.
Resources Mentioned:
https://www.linkedin.com/in/mikeblankenship/
Winston & Strawn LLP | LinkedIn -
https://www.linkedin.com/company/winston-&-strawn-llp/
https://www.winston.com
https://www.sec.gov/rules-regulations/jumpstart-our-business-startups-jobs-act
https://www.londonstockexchange.com/
https://www.euronext.com/en
SEC (US Securities and Exchange Commission) -
https://www.sec.gov/
FINRA (Financial Industry Regulatory Authority) -
https://www.finra.org/
FDA (Food and Drug Administration) -
https://www.fda.gov/
IRA (Inflation Reduction Act) -
https://home.treasury.gov/policy-issues/inflation-reduction-act
Thanks for listening to the “Global Workforce Podcast”. If you enjoyed this episode, please leave a 5-star review. And be sure to subscribe so you never miss any insightful conversations.
#WorkforcePodcast #GlobalExpansion #WorkforceCompliance #RemoteWork
